The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures such as monitoring of acetaminophen ...

With the Dexcom G6, the sensor is worn separately from an insulin pump and is inserted under the skin to measure the level of glucose in the interstitial fluid (fluid in the tissue).

A trade-off with the Dexcom G6: Because there are no more finger sticks, FDA has required that the sensor shut off after 10 days, so that patients change sensors to ensure accuracy.

DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.

The availability of DexCom's (DXCM) G6 CGM System to diabetic TRICARE military members is expected to enable them to make better real-time decisions about their health.

Dexcom G6 uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a smart device * or receiver, giving patients real-time glucose data without ...

When available, a new Dexcom patient can order and current users can upgrade to the Dexcom G6 system, which includes a new G6 transmitter and sensors.

Dexcom G6 users will now be able to integrate their continuous glucose monitor to the Livongo platform for more personalized insights and coaching.